Drugs / Ex Vivo CD3/CD28 costimulated Umbilical Cord Blood T cells
Ex Vivo CD3/CD28 costimulated Umbilical Cord Blood T cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00891592 | Jan 2009 → Nov 2011 | Hodgkins lymphoma, acute myeloid leukemia, chronic myeloid leukemia, myelodysplastic syndrome +2 | University of Pennsylvania | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ex Vivo CD3/CD28 costimulated Umbilical Cord Blood T cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00891592 ↗ |
| Modality | Cell therapy | “ex vivo activation by CD3/CD28 costimulation and expansion of T cells from a single UCB graft” PMID 26858124 ↗ Apr 2016 |